Guided Antitumoural Drugs: (Imidazol‐2‐ylidene)(L)gold(I) Complexes Seeking Cellular Targets Controlled by the Nature of Ligand L

Three [1,3‐diethyl‐4‐(p‐methoxyphenyl)‐5‐(3,4,5‐trimethoxyphenyl)imidazol‐2‐ylidene](L)gold(I) complexes, 4 a (L=Cl), 5 a (L=PPh(3)), and 6 a (L=same N‐heterocyclic carbene (NHC)), and their fluorescent [4‐(anthracen‐9‐yl)‐1,3‐diethyl‐5‐phenylimidazol‐2‐ylidene](L)gold(I) analogues, 4 b, 5 b, and 6 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Bär, Sofia I., Gold, Madeleine, Schleser, Sebastian W., Rehm, Tobias, Bär, Alexander, Köhler, Leonhard, Carnell, Lucas R., Biersack, Bernhard, Schobert, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986617/
https://www.ncbi.nlm.nih.gov/pubmed/33369765
http://dx.doi.org/10.1002/chem.202005451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986617/
https://www.ncbi.nlm.nih.gov/pubmed/33369765
http://dx.doi.org/10.1002/chem.202005451

Ejemplares similares